Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Capital Expenditures (2016 - 2026)

Agios Pharmaceuticals (AGIO) has disclosed Capital Expenditures for 15 consecutive years, with $668000.0 as the latest value for Q1 2026.

  • For Q1 2026, Capital Expenditures fell 12.79% year-over-year to $668000.0; the TTM value through Mar 2026 reached $185000.0, down 92.45%, while the annual FY2025 figure was $283000.0, 83.2% down from the prior year.
  • Capital Expenditures hit $668000.0 in Q1 2026 for Agios Pharmaceuticals, up from -$53000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $4.8 million in Q3 2022 and bottomed at -$1.5 million in Q2 2022.
  • Average Capital Expenditures over 5 years is $532250.0, with a median of $301500.0 recorded in 2023.
  • Year-over-year, Capital Expenditures surged 25500.0% in 2022 and then crashed 6968.42% in 2025.
  • Agios Pharmaceuticals' Capital Expenditures stood at $113000.0 in 2022, then soared by 107.08% to $234000.0 in 2023, then soared by 594.02% to $1.6 million in 2024, then tumbled by 103.26% to -$53000.0 in 2025, then soared by 1360.38% to $668000.0 in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $668000.0, -$53000.0, and -$1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.